Cell-Based Platform for Antigen Testing and Its Application for SARS-CoV-2 Infection
Abstract
Pandemic mitigation requires continuous testing of symptomatic or asymptomatic individuals with rapid turnaround time, and lack of this capability in our community has prolonged pandemic duration leading to obliteration of world economies. The DxCell platform is a cell-based self-replicative antigen test that detects molecular signatures of the target pathogen and can be distributed in small quantities to testing facilities for expansion on site to the desired volume.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Aug 31, 2022
- Source ID
- 10.1128/spectrum.00731-22
Entities
People
- Harikrishnan Radhakrishnan
- Harold S Javitz
- Juan Arredondo
- Marvin A. Ssemadaali
- Parijat Bhatnagar
- Satya Dandekar
- Sherri L. Newmyer
Organizations
- National Cancer Institute
- National Institute of Biomedical Imaging and Bioengineering
- SRI International